Suppr超能文献

一名患有肾性尿崩症的丹麦男性的AVPR2基因发生新突变,该突变导致受体在内质网滞留并随后被溶酶体降解。

Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor.

作者信息

Nejsum Lene N, Christensen Tomas M, Robben Joris H, Milligan Graeme, Deen Peter M T, Bichet Daniel G, Levin Klaus

机构信息

Department of Biology, Stanford University, Stanford, CA, USA.

出版信息

NDT Plus. 2011 Jun;4(3):158-163. doi: 10.1093/ndtplus/sfr010. Epub 2011 Mar 2.

Abstract

Mutations in the arginine vasopressin receptor 2 (AVPR2) gene can cause X-linked nephrogenic diabetes insipidus (NDI) characterized by the production of large amounts of urine and an inability to concentrate urine in response to the antidiuretic hormone vasopressin. We have identified a novel mutation in the AVPR2 gene (L170P) located in the fourth transmembrane domain in a Danish NDI male. Analysis of the mutant receptor in Madin-Darby Canine Kidney cell culture revealed that AVPR2-L170P was retained in the endoplasmic reticulum, and the expression was dramatically downregulated compared to wild-type AVPR2. Inhibition of the lysosome resulted in increased intracellular accumulation of AVPR2-L170P, indicating that AVPR2-L170P is downregulated via the lysosome. Inhibition of the proteasome resulted in plasma membrane localization of AVPR2-L170P, although the overall levels of AVPR2-L170P were unchanged.

摘要

精氨酸加压素受体2(AVPR2)基因突变可导致X连锁肾性尿崩症(NDI),其特征是产生大量尿液,且对抗利尿激素加压素无反应,无法浓缩尿液。我们在一名丹麦NDI男性中鉴定出位于第四跨膜结构域的AVPR2基因中的一个新突变(L170P)。在Madin-Darby犬肾细胞培养物中对突变受体的分析显示,AVPR2-L170P保留在内质网中,与野生型AVPR2相比,其表达显著下调。溶酶体的抑制导致AVPR2-L170P在细胞内的积累增加,表明AVPR2-L170P通过溶酶体被下调。蛋白酶体的抑制导致AVPR2-L170P定位于质膜,尽管AVPR2-L170P的总体水平未改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/150b/3103721/e7449c719538/ndtplussfr010f01_lw.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验